Pilosoma - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 46,971 | 40,410 | 34,927 | 38,614 | 58,678 | 134,619 | 212,131 | 202,760 |
| Profit before tax | - | - | - | - | - | - | - | - |
| Net profit | -2,804 | -6,105 | 2,823 | 3,692 | 1,349 | 9,426 | 5,446 | -1,936 |
| Equity | 4,562 | -1,543 | 1,280 | 4,972 | 6,321 | 15,747 | 21,193 | 19,257 |
| Liabilities | 11,205 | 12,040 | 7,500 | 9,226 | 4,982 | 11,719 | 6,972 | 6,477 |
| Non-current assets | 12 | 12 | 823 | 803 | 990 | 2,833 | 4,063 | 2,729 |
| Current assets | 15,755 | 10,485 | 7,957 | 13,309 | 10,313 | 24,499 | 24,022 | 22,887 |
| Total assets | 15,767 | 10,497 | 8,780 | 14,112 | 11,303 | 27,332 | 28,085 | 25,616 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 4,189 | 5,142 | 4,583 |
|
Financial indicators
|
||||||||
| Revenue change y/y | +3.9% | -14.0% | -13.6% | +10.6% | +52.0% | +129.4% | +57.6% | -4.4% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | -17.8% | -58.2% | 32.2% | 26.2% | 11.9% | 34.5% | 19.4% | -7.6% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | -61.5% | - | 220.5% | 74.3% | 21.3% | 59.9% | 25.7% | -10.1% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | -6.0% | -15.1% | 8.1% | 9.6% | 2.3% | 7.0% | 2.6% | -1.0% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | - | - | - | - | - | - | - | - |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 2.5 | - | 5.9 | 1.9 | 0.8 | 0.7 | 0.3 | 0.3 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 15,657 | 13,470 | 11,642 | 17,822 | 44,010 | 134,619 | 181,821 | 187,169 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Pilosoma - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2025-01-16 | 2025-01-19 | 1.00 |
| 2025-01-02 | 2025-01-05 | 1.00 |
| 2024-12-22 | 2024-12-31 | 1.00 |
| 2024-12-17 | 2024-12-20 | 1.00 |
| 2024-11-18 | 2024-12-09 | 1.00 |
| 2024-10-16 | 2024-11-05 | 1.00 |
| 2022-12-16 | 2023-01-05 | 0.01 |
| 2022-11-21 | 2022-12-04 | 0.01 |
| 2022-11-17 | 2022-11-18 | 0.01 |
| 2022-10-18 | 2022-11-07 | 0.01 |
| 2022-09-16 | 2022-10-05 | 0.01 |
| 2022-08-23 | 2022-09-07 | 0.01 |
| 2022-07-18 | 2022-08-09 | 0.01 |
| 2022-06-16 | 2022-07-13 | 0.01 |
| 2022-05-17 | 2022-06-08 | 0.01 |
Pilosoma - VMI tax arrears
The company had no tax arrears (debts) to the State Tax Inspectorate
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Pilosoma, UAB (code 136017166) is a Private Limited Liability Company engaged in the wholesale of lubricants and additives. In 2025, revenue amounted to €202.8K, down 4.4% year on year after increasing from €134.6K in 2023 to €212.1K in 2024. The company moved from profit to loss in 2025, posting a net loss of €1.9K versus net profit of €9.4K in 2023 and €5.4K in 2024. The profit margin stood at -0.9%. Over the three-year period, revenue grew materially overall, but profitability weakened in the latest year. At the end of 2025, total assets were €25.6K, equity €19.3K and liabilities €6.5K. The equity ratio was 75.2% and debt-to-equity 0.34, pointing to a relatively conservative capital structure. Asset turnover was 7.92x, while revenue per employee was €202.8K and profit per employee was -€1.9K. ROE was -10.1% and ROA -7.6% in 2025.